17-18142823-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_016239.4(MYO15A):c.5893C>T(p.Arg1965Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000825 in 1,612,782 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1965H) has been classified as Likely benign.
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000408 AC: 10AN: 244870 AF XY: 0.0000375 show subpopulations
GnomAD4 exome AF: 0.0000849 AC: 124AN: 1460618Hom.: 0 Cov.: 34 AF XY: 0.0000826 AC XY: 60AN XY: 726514 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74340 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1Benign:1
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
The p.Arg1965Cys variant in MYO15A has not been reported in individuals with hea ring loss, but has been identified in 8/55000 of European chromosomes by the Exo me Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3744856 49). Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Arg1 965Cys variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.5893C>T (p.R1965C) alteration is located in exon 25 (coding exon 24) of the MYO15A gene. This alteration results from a C to T substitution at nucleotide position 5893, causing the arginine (R) at amino acid position 1965 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at